Contact
searchSearch
HMP Global

Multiple Myeloma

New & Trending

Beth Faiman, CNP, PhD, Cleveland Clinic
Videos
Case 2: A Patient With Multi-Relapsed Multiple Myeloma
07/21/2025
Beth Faiman, CNP, PhD
Beth Faiman, CNP, PhD, discusses treatment decision-making for a patient with multiple myeloma whose disease relapsed through several lines of therapy.
Beth Faiman, CNP, PhD, discusses treatment decision-making for a patient with multiple myeloma whose disease relapsed through several lines of therapy.
Beth Faiman, CNP, PhD, discusses...
07/21/2025
Oncology Learning Network APP Institute
Beth Faiman, CNP, PhD, Cleveland Clinic
Videos
Case 1: A Patient With Symptomatic Multiple Myeloma
07/21/2025
Beth Faiman, CNP, PhD
Beth Faiman, CNP, PhD, discusses treatment decision-making for a patient with symptomatic relapsed multiple myeloma.
Beth Faiman, CNP, PhD, discusses treatment decision-making for a patient with symptomatic relapsed multiple myeloma.
Beth Faiman, CNP, PhD, discusses...
07/21/2025
Oncology Learning Network APP Institute
Beth Faiman & Donna Catamero
Clinical Pearls
2025 Updates on Bispecific Antibody Therapy for Multiple Myeloma
07/11/2025
Beth Faiman, CNP, PhD; Donna Catamero, NP
Beth Faiman, CNP, PhD, and Donna Catamero, NP, discuss updates in multiple myeloma from the 2025 ASCO Annual Meeting and EHA Congress, highlighting pivotal studies exploring the use of bispecifics in earlier lines of treatment and emerging...
Beth Faiman, CNP, PhD, and Donna Catamero, NP, discuss updates in multiple myeloma from the 2025 ASCO Annual Meeting and EHA Congress, highlighting pivotal studies exploring the use of bispecifics in earlier lines of treatment and emerging...
Beth Faiman, CNP, PhD, and Donna...
07/11/2025
Oncology Learning Network APP Institute
Beth Faiman & Donna Catamero
Clinical Pearls
Bispecific Antibodies for Multiple Myeloma: Patient Selection, Sequencing, and Adverse Event Management
07/11/2025
Beth Faiman, CNP, PhD; Donna Catamero, NP
Beth Faiman, CNP, PhD, and Donna Catamero, NP, discuss bispecific antibody therapy for multiple myeloma and important considerations for patient selection and side effect management, highlighting recent data and real-world applications.
Beth Faiman, CNP, PhD, and Donna Catamero, NP, discuss bispecific antibody therapy for multiple myeloma and important considerations for patient selection and side effect management, highlighting recent data and real-world applications.
Beth Faiman, CNP, PhD, and Donna...
07/11/2025
Oncology Learning Network APP Institute
Caroline Schinke, MD
Oncology Advances
Evaluating Long-Term Efficacy and Safety Results from MonumenTAL-1 on Talquetamab Treatment for Patients With Multiple Myeloma
08/09/2024
Caroline Schinke, MD, Myeloma Center at the University of Arkansas, speaks about the long-term efficacy and safety results from the MonumenTAL-1 trials on talquetamab treatment among patients with MM.
Caroline Schinke, MD, Myeloma Center at the University of Arkansas, speaks about the long-term efficacy and safety results from the MonumenTAL-1 trials on talquetamab treatment among patients with MM.
Caroline Schinke, MD, Myeloma...
08/09/2024
Oncology Learning Network APP Institute
Samantha Shenoy
Videos
Management Considerations for Oral Toxicities Associated With Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma
05/09/2024
Samantha Shenoy, NP, discusses considerations for nurses and advanced practitioners managing patients with relapsed/refractory multiple myeloma experiencing oral toxicities after treatment with talquetamab.
Samantha Shenoy, NP, discusses considerations for nurses and advanced practitioners managing patients with relapsed/refractory multiple myeloma experiencing oral toxicities after treatment with talquetamab.
Samantha Shenoy, NP, discusses...
05/09/2024
Oncology Learning Network APP Institute
Beth Finley-Oliver and Rachid Baz, Moffitt Cancer Center
Clinical Pearls
Individualizing Care for Multiple Myeloma: Navigating Treatment Options and Addressing Patient Needs
11/27/2023
Elizabeth Finley-Oliver, ARNP, MSN; Rachid Baz, MD
Elizabeth Finley-Oliver, MSN, ARNP, AGNP-BC, and Rachid Baz, MD, discuss the treatment landscape for patients with multiple myeloma and how clinicians can individualize care while addressing patient needs.
Elizabeth Finley-Oliver, MSN, ARNP, AGNP-BC, and Rachid Baz, MD, discuss the treatment landscape for patients with multiple myeloma and how clinicians can individualize care while addressing patient needs.
Elizabeth Finley-Oliver, MSN,...
11/27/2023
Oncology Learning Network APP Institute
Lorinda Coombs
APP Perspectives
Myeloma Care: Patient and Advanced Practice Provider Perspectives
11/17/2023
Lorinda Coombs, PhD, CNS, FNP-BC
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS,...
11/17/2023
Oncology Learning Network APP Institute

Clinical Pearls

APP Perspectives

Lorinda Coombs
APP Perspectives
Myeloma Care: Patient and Advanced Practice Provider Perspectives
11/17/2023
Lorinda Coombs, PhD, CNS, FNP-BC
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS,...
11/17/2023
Oncology Learning Network APP Institute
Lorinda Coombs
APP Perspectives
Myeloma Care: Patient and Advanced Practice Provider Perspectives
11/17/2023
Lorinda Coombs, PhD, CNS, FNP-BC
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS,...
11/17/2023
Oncology Learning Network APP Institute

Conference Coverage

Lorinda Coombs
APP Perspectives
Myeloma Care: Patient and Advanced Practice Provider Perspectives
11/17/2023
Lorinda Coombs, PhD, CNS, FNP-BC
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS, FNP-BC, AOCNP, discusses results from a survey that inform patients and advanced practice provider perspectives on myeloma care.
Lorinda Coombs, PhD, CNS,...
11/17/2023
Oncology Learning Network APP Institute
Conference Coverage
Qualitative Study Examines How Cancer Patients Define Stress Versus Distress
05/19/2026
Kirra Fedyszyn
Study findings show cancer patients undergoing radiation therapy may interpret “stress” and “distress” differently—or use the terms interchangeably—raising important considerations for symptom assessment and supportive oncology care.
Study findings show cancer patients undergoing radiation therapy may interpret “stress” and “distress” differently—or use the terms interchangeably—raising important considerations for symptom assessment and supportive oncology care.
Study findings show cancer...
05/19/2026
Oncology Learning Network APP Institute
Conference Coverage
Oncology APP-Led Telehealth May Enhance Cancer Symptom Self-Management
05/19/2026
Kirra Fedyszyn
Advanced practice provider (APP)-led telehealth education increased patient engagement in cancer symptom self-management, with patients making significantly more proactive symptom support calls during treatment. However, the intervention did...
Advanced practice provider (APP)-led telehealth education increased patient engagement in cancer symptom self-management, with patients making significantly more proactive symptom support calls during treatment. However, the intervention did...
Advanced practice provider...
05/19/2026
Oncology Learning Network APP Institute
Conference Coverage
Patient Navigation Platform May Improve Oncology Care Coordination and Staff Efficiency
05/18/2026
Kirra Fedyszyn
A patient-navigation platform designed to address social determinants of health may improve workflow efficiency and social support delivery in community oncology practices, according to preliminary implementation data.
A patient-navigation platform designed to address social determinants of health may improve workflow efficiency and social support delivery in community oncology practices, according to preliminary implementation data.
A patient-navigation platform...
05/18/2026
Oncology Learning Network APP Institute
Conference Coverage
Community-Based HPV Screening Initiative Targets Cervical Cancer Disparities in People Experiencing Homelessness
05/18/2026
Kirra Fedyszyn
Community health worker-led education and human papillomavirus (HPV) self-sampling may improve cervical cancer screening access among women experiencing homelessness, a population with disproportionately high cervical cancer burden.
Community health worker-led education and human papillomavirus (HPV) self-sampling may improve cervical cancer screening access among women experiencing homelessness, a population with disproportionately high cervical cancer burden.
Community health worker-led...
05/18/2026
Oncology Learning Network APP Institute
Conference Coverage
Cognitive Variability Linked to Lower Quality of Life in Metastatic Breast Cancer Survivors
05/18/2026
Kirra Fedyszyn
Daily fluctuations in cognitive symptoms may predict lower quality of life and greater social dysfunction in women living with metastatic breast cancer, according to prospective real-world assessment data.
Daily fluctuations in cognitive symptoms may predict lower quality of life and greater social dysfunction in women living with metastatic breast cancer, according to prospective real-world assessment data.
Daily fluctuations in cognitive...
05/18/2026
Oncology Learning Network APP Institute
Conference Coverage
Rural Cancer Program Expands Local Access to BiTE Therapy
05/18/2026
Kirra Fedyszyn
A rural cancer program successfully implemented local administration of bispecific T-cell engager (BiTE) therapy, reducing travel burden while safely delivering treatment for patients with hematologic malignancies.
A rural cancer program successfully implemented local administration of bispecific T-cell engager (BiTE) therapy, reducing travel burden while safely delivering treatment for patients with hematologic malignancies.
A rural cancer program...
05/18/2026
Oncology Learning Network APP Institute
Conference Coverage
Multimodal Nurse Training Improves Recognition of Cellular Immunotherapy Toxicities
05/18/2026
Kirra Fedyszyn
A multimodal education program achieved high competency rates among inpatient and outpatient nurses in recognizing and managing toxicities associated with cellular immunotherapies, including cytokine release syndrome (CRS) and immune effector...
A multimodal education program achieved high competency rates among inpatient and outpatient nurses in recognizing and managing toxicities associated with cellular immunotherapies, including cytokine release syndrome (CRS) and immune effector...
A multimodal education program...
05/18/2026
Oncology Learning Network APP Institute
Conference Coverage
Practical Strategies for Monitoring and Managing T-DXd-Related ILD in Clinical Settings
05/18/2026
Kirra Fedyszyn
Expert guidance highlights the critical role oncology nurses and advanced practice providers play in early recognition and management of trastuzumab deruxtecan-related interstitial lung disease in routine cancer care.
Expert guidance highlights the critical role oncology nurses and advanced practice providers play in early recognition and management of trastuzumab deruxtecan-related interstitial lung disease in routine cancer care.
Expert guidance highlights the...
05/18/2026
Oncology Learning Network APP Institute
Conference Coverage
Molecular Residual Disease Testing Expanding Across US Cancer Care Settings
05/15/2026
Kirra Fedyszyn
Real-world data show rapid growth in utilization of molecular residual disease (MRD) testing in the United States, across multiple cancer types, with increasing use beyond early-stage settings into advanced and metastatic disease.
Real-world data show rapid growth in utilization of molecular residual disease (MRD) testing in the United States, across multiple cancer types, with increasing use beyond early-stage settings into advanced and metastatic disease.
Real-world data show rapid...
05/15/2026
Oncology Learning Network APP Institute
Conference Coverage
Study Links Gut Microbiome to Symptom Burden in Patients With Melanoma on Immunotherapy
05/15/2026
Kirra Fedyszyn
Emerging evidence links gut microbiome profiles to fatigue and other psychoneurological symptoms in melanoma patients receiving immune checkpoint inhibitors, suggesting a potential biological pathway for symptom burden during treatment.
Emerging evidence links gut microbiome profiles to fatigue and other psychoneurological symptoms in melanoma patients receiving immune checkpoint inhibitors, suggesting a potential biological pathway for symptom burden during treatment.
Emerging evidence links gut...
05/15/2026
Oncology Learning Network APP Institute
Oncology Learning Network APP Institute logo

The APP Institute is a new offering from the Oncology Learning Network that provides microburst education to oncology advanced practitioners. The platform offers year-round digital non-accredited learning modules through animated short videos, multimedia interviews with key opinion leaders, interactive content to test your knowledge, and more!

 

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use